AstraZeneca PLC (ZEG.F)
Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
At close: 07:22PM CEST
| Previous close | 142.85 |
| Open | 143.10 |
| Bid | 140.95 x 40000 |
| Ask | 142.25 x 40000 |
| Day's range | 142.25 - 143.10 |
| 52-week range | 112.45 - 158.15 |
| Volume | |
| Avg. volume | 640 |
| Market cap | 221.237B |
| Beta (5Y monthly) | 0.17 |
| PE ratio (TTM) | 38.55 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.73 (1.91%) |
| Ex-dividend date | 08 Aug 2024 |
| 1y target est | N/A |
- Zacks
AstraZeneca's Calquence sNDA Gets FDA Priority Tag for Expanded Use
The FDA grants priority review to AZN's sNDA for Calquence for untreated mantle cell lymphoma. A decision is expected in first-quarter 2025.
- Simply Wall St.
3 UK Stocks Estimated To Be Trading Below Their Intrinsic Value
The UK stock market has recently faced challenges, with the FTSE 100 index experiencing declines due to weak trade data from China and broader global economic concerns. As investors navigate these uncertain conditions, identifying stocks that are trading below their intrinsic value can present potential opportunities for those seeking to capitalize on mispriced assets.
- Zacks
AstraZeneca's Enhertu sBLA Gets FDA Priority Tag for Expanded Use
The FDA grants priority review to AZN's sBLA for Enhertu to treat HER2-low or HER2-ultralow metastatic breast cancer. A decision is due in first-quarter 2025.
© 2024 Yahoo. All rights reserved.